| Cat. No. |
Product Name |
Information |
| PC-20793 |
IHMT-RAF-128
pan-RAF inhibitor
|
IHMT-RAF-128 is a highly potent pan-RAF inhibitor with IC50 of 5.9 and 3.6 nM for BRAF-V600E and CRAF, respectively. |
| PC-49770 |
Encorafenib
BRAF inhibitor
|
Encorafenib (NVP-LGX818, LGX818) a potent, selective BRAF inhibitor with IC50 of 0.35, 0.47, and 0.3 nM against BRAF V600E, wild-type BRAF and CRAF in vitro cell-free assays, respectively. |
| PC-73450 |
AZ-628
pan-RAF inhibitor
|
AZ-628 (AZD-628, AZ628) is a potent, selective, pan-RAF kinase inhibitor with IC50 of 105, 29 and 34 nM against for wild-type CRAF, BRAF V600E, and c-Raf-1, respectively. |
| PC-73449 |
Tovorafenib
pan-RAF inhibitor
|
Tovorafenib (MLN2480, TAK-580) is potent, selective, brain-penetrant RAF dimer antagonist, inhibits MAP kinase pathway signaling in BRAF-mutant melanoma models. |
| PC-72612 |
PF-07284890
BRAF V600 mutants inhibitor
|
Tinlorafenib (PF-07284890, ARRY-461) is an orally bioavailable, brain penetrant, potent, small molecule BRAF V600 mutants inhibitor, inhibits BRAF and CRAF with IC50 of 5.8 and 4.1 nM, respectively. |
| PC-72530 |
TAK-632
RAF inhibitor, RIPK3 inhibitor
|
TAK-632 (TAK632) is a potent, selective pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF V600E and BRAF WT, respectively. |
| PC-72469 |
GNE-9815
pan-RAF inhibitor
|
GNE-9815 (GNE9815) is a potent, selective, oral Type II pan-RAF inhibitor with Ki of 0.062 and 0.19 nM for CRAF and BRAF, respectively. |
| PC-72243 |
RG6344
BRAF inhibitor
|
Mosperafenib (RG6344, RO7276389) is a potent, selective, brain penetrant BRAF inhibitor with binding Kd of 0.6, 1.2, and 1.7 nM for BRAF WT, BRAF V600E, and c-RAF, presenting paradox breaker properties. |
| PC-72242 |
PLX8394
BRAF inhibitor
|
PLX8394 (Plixorafenib, FORE8394) is a next-generation, orally available, small-molecule BRAF inhibitor with IC50 values of 3.8 nM, 14 nM and 23 nM for BRAF (V600E), WT BRAF and CRAF, respectively. |
| PC-35635 |
LXH254
BRAF/CRAF inhibitor
|
LXH254 (Naporafenib, LXH-254) is a highly potent, selective B/C RAF inhibitor with Kd of 1.3/3.6 nM respectively, shows less activity against ARAF. |
| PC-35347 |
Balamapimod
Ras inhibitor
|
Balamapimod (MKI-833) is an orally active, reversible Ras/Raf/MEK inhibitor developed for antineoplastic potential. |
| PC-35100 |
RRD-251
Rb/Raf-1 inhibitor
|
RRD-251 is a small molecule disruptor of Rb/Raf-1 interaction, potently and selectively disrupts the Rb/Raf-1 (IC50=77 nM) but not Rb/E2F, Rb/prohibitin, Rb/cyclin E, and Rb/HDAC binding. |
